Search

PhagoMed, an Austrian phage therapy company, announced this week that it’s received 1.5 million Euro in additional investment!

The Cystic Fibrosis Foundation, a world-leading non-profit that drives CF research and development, has teamed up with CARB-X, a global partnership investing in antibacterial innovation, in pursuit of a new Infection Research Initiative. Th

The Cystic Fibrosis Foundation, a world-leading non-profit that drives CF research and development, has teamed up with CARB-X, a global partnership investing in antibacterial innovation, in pursuit of a new Infection Research Initiative. Th

Micreos, a Dutch phage biotech company, secured 30 million Euro last month for its phage lysin technology. The company plans to use the funds for lysin development, and to launch its over-the-counter Gladskin product (anti-Staph aureus lysi

Micreos, a Dutch phage biotech company, secured 30 million Euro last month for its phage lysin technology. The company plans to use the funds for lysin development, and to launch its over-the-counter Gladskin product (anti-Staph aureus lysi

NCMAS’s 2026 round allocated merit-reviewed access to the NCI Gadi and Pawsey Setonix supercomputers. Applications closed on October 31, 2025 at 8pm AEDT / 5pm AWST. This is the 2026 allocation edition, separate from the 2027 call. NCMAS /

The programme supports researchers beginning their careers at a new institution with up to ₹60 lakh plus overheads for three years. Support can cover staff, project-related travel, open-access publication and patent costs. The programme pag

Noda’s new 2027 consortium call supports two-person collaborations between a fermentation-science researcher and a researcher from another discipline. Each selected group can receive ¥26 million per year, including indirect costs, for April

The final application cycle supports African faculty researchers for two years, including one year in Ann Arbor from summer 2027. Support includes a $35,000 residence stipend, housing, travel and a $50,000 pilot grant on return to Africa. B

Ersilia and H3D’s six-month AI Incubator supports African-led small-molecule drug-discovery projects for infectious diseases. Selected projects receive US$10,000, mentoring and funded in-person participation. Applications close on October 1

JST and BRIN’s 2025 Japan–Indonesia joint call supported up to three years of collaborative bioproduction research. Japanese-side support included ¥24 million in direct expenses plus 30% indirect expenses; Indonesian-side support was up to

DHR’s 2026–27 health-research call offered short-term studentships for MBBS/BDS students and thesis support for MD/MS/DM/MCH/DNB/DrNB/MDS students. A May 30 notice extended both components’ application deadline to June 10, 2026 at 5pm. Appl

January 2025: Project funding and PhD scholarships awarded for two MQ BioInnovation projects: “Designing RNA with Custom Properties using AI” and “Towards Total Digital Control of Biological Systems.” Jaschke Lab

The programme supports research capacity and German-laboratory collaborations in selected Middle Eastern and North African countries, including biotechnology, AI and health research. PhD investigators need an eligible-country appointment an

Pathfinder Projects support practical solutions for FAIR and AI-ready life-science data and workflows. The first round offered up to £100,000 for twelve months to UK research organizations eligible for UKRI funding. It closed December 15, 2

Conquer Cystic Fibrosis and the McCusker Charitable Foundation offered up to A$200,000 over two years for phage-therapy research into antimicrobial-resistant infections, including cystic fibrosis. Both the research and lead investigator had

An ERC Advanced Grant will support the Brouns lab’s research for five years. Brouns lab — owned dated news recap

IUBMB, FEBS and PABMB supported three- to six-month research visits for Latin American PhD students and early-career researchers at host laboratories in FEBS countries. Awards ranged from €4,500 for three months to €7,000 for six months, co

NIAID’s R21 call supported basic and translational research on phage biology relevant to preventing and treating drug-resistant bacterial infections. Applications closed on March 18, 2020. The listing gave US$2.5 million as total programme

Phage Arab’s BAPA 2026 award recognises Arab researchers working on distinctive phages from the Middle East and North Africa. Its announcement invites researchers with a newly isolated phage registered in NCBI GenBank to apply by October 20